Endothelin and myocardial ischemia

David Hasdai*, Ran Kornowski, Alexander Battler

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


Endothelin is a potent vasoconstrictor with a wide range of effects on the heart. Changes in myocardial and circulating levels of endothelin have been described in various experimental models of myocardial ischemia, and in humans with acute myocardial infarction and different forms of angina pectoris. The role played by endothelin in the different states of myocardial ischemia is unclear. However, myocardial damage has been shown to be reduced in several experimental models of myocardial infarction by administering agents that block the action of endothelin. The aim of this review article is to present the current literature concerning the interaction between endothelin and the various forms of myocardial ischemia, and to explore the significance of such interactions.

Original languageEnglish
Pages (from-to)589-599
Number of pages11
JournalCardiovascular Drugs and Therapy
Issue number4
StatePublished - Aug 1994


  • angina pectoris
  • endothelin
  • heart
  • myocardial infarction
  • myocardial ischemia
  • reperfusion


Dive into the research topics of 'Endothelin and myocardial ischemia'. Together they form a unique fingerprint.

Cite this